A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223
Condition: Prostatic Neoplasms, Castration-Resistant Intervention: Drug: Radium-223 (Xofigo, Bay88-8223) Sponsor: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials